BIORESTORATIVE THERAPIES, INC. (BRTX) Net margin 2016–2025
BIORESTORATIVE THERAPIES, INC. (BRTX) net profit margin by fiscal year — reported net income divided by reported revenue.
-3959.4%FY2025 · since FY2016: -23755.4% → -3959.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -3959.4% | -1720.2 pp |
| FY2024 | -2239.2% | +4906.0 pp |
| FY2023 | -7145.2% | +3891.8 pp |
| FY2022 | -11037.0% | +85274.5 pp |
| FY2021 | -96311.5% | -81671.7 pp |
| FY2020 | -14639.9% | -3372.2 pp |
| FY2019 | -11267.6% | +9.7 pp |
| FY2018 | -11277.3% | +382.8 pp |
| FY2017 | -11660.1% | +12095.4 pp |
| FY2016 | -23755.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BRTX financial trends
BRTX RevenueBRTX Net incomeBRTX Gross profitBRTX Gross marginBRTX Operating incomeBRTX Operating marginBRTX Operating cash flowBRTX Free cash flowBRTX Capital expendituresBRTX Return on equityBRTX Stock buybacksBRTX Dividends paidBRTX Total assetsBRTX Total liabilitiesBRTX Shareholders’ equityBRTX overview →